Literature DB >> 8910365

p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2.

R M Kramer1, E F Roberts, S L Um, A G Börsch-Haubold, S P Watson, M J Fisher, J A Jakubowski.   

Abstract

The Ca2+-sensitive 85-kDa cytosolic phospholipase A2 (cPLA2) is responsible for thrombin-stimulated mobilization of arachidonic acid for the synthesis of thromboxane A2 in human platelets. We have previously shown that thrombin activates p38 kinase, a recently discovered new member of the mitogen-activated protein kinase family (Kramer, R. M., Roberts, E. F., Strifler, B. A., and Johnstone, E. M. (1995) J. Biol. Chem. 270, 27395-27398) and also induces phosphorylation of cPLA2, thereby increasing its intrinsic catalytic activity. In the present study we have examined the role of p38 kinase in the phosphorylation and activation of cPLA2 in stimulated platelets. We have observed that activation of p38 kinase accompanies receptor-mediated events in platelets and coincides with cPLA2 phosphorylation. Furthermore, in the presence of inhibitors of p38 kinase, the proline-directed phosphorylation of cPLA2 was completely blocked in platelets stimulated with the thrombin receptor agonist peptide SFLLRN and was suppressed during the early (up to 2 min) phase of platelet stimulation caused by thrombin. Unexpectedly, we found that prevention of proline-directed phosphorylation of cPLA2 in stimulated platelets did not attenuate its ability to release arachidonic acid from platelet phospholipids. We conclude that: 1) cPLA2 is a physiological target of p38 kinase; 2) p38 kinase is involved in the early phosphorylation of cPLA2 in stimulated platelets; and 3) proline-directed phosphorylation of cPLA2 is not required for its receptor-mediated activation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910365     DOI: 10.1074/jbc.271.44.27723

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  86 in total

1.  Low-density lipoprotein activates the small GTPases Rap1 and Ral in human platelets.

Authors:  C M Hackeng; B Franke; I A Relou; G Gorter; J L Bos; H J van Rijn ; J W Akkerman
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

Review 2.  TNF ligands and receptors--a matter of life and death.

Authors:  David J MacEwan
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

3.  Synergistic induction of cyclooxygenase-2 by transforming growth factor-beta1 and epidermal growth factor inhibits apoptosis in epithelial cells.

Authors:  D Saha; P K Datta; H Sheng; J D Morrow; M Wada; H L Moses; R D Beauchamp
Journal:  Neoplasia       Date:  1999-12       Impact factor: 5.715

4.  Complement-independent Ab-induced peroxide lysis of platelets requires 12-lipoxygenase and a platelet NADPH oxidase pathway.

Authors:  Michael Nardi; Steven J Feinmark; Liang Hu; Zongdong Li; Simon Karpatkin
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

5.  Improved platelet survival after cold storage by prevention of glycoprotein Ibα clustering in lipid rafts.

Authors:  Eelo Gitz; Cornelis A Koekman; Dave J van den Heuvel; Hans Deckmyn; Jan W Akkerman; Hans C Gerritsen; Rolf T Urbanus
Journal:  Haematologica       Date:  2012-06-24       Impact factor: 9.941

Review 6.  Cytosolic phospholipase A₂: physiological function and role in disease.

Authors:  Christina C Leslie
Journal:  J Lipid Res       Date:  2015-04-02       Impact factor: 5.922

7.  Glucose and collagen regulate human platelet activity through aldose reductase induction of thromboxane.

Authors:  Wai Ho Tang; Jeremiah Stitham; Scott Gleim; Concetta Di Febbo; Ettore Porreca; Cristiano Fava; Stefania Tacconelli; Marta Capone; Virgilio Evangelista; Giacomo Levantesi; Li Wen; Kathleen Martin; Pietro Minuz; Jeffrey Rade; Paola Patrignani; John Hwa
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

8.  Role of phosphorylation and basic residues in the catalytic domain of cytosolic phospholipase A2alpha in regulating interfacial kinetics and binding and cellular function.

Authors:  Dawn E Tucker; Moumita Ghosh; Farideh Ghomashchi; Robyn Loper; Saritha Suram; Bonnie St John; Milena Girotti; James G Bollinger; Michael H Gelb; Christina C Leslie
Journal:  J Biol Chem       Date:  2009-01-28       Impact factor: 5.157

9.  Docosahexaenoic acid and arachidonic acid release in rat brain astrocytes is mediated by two separate isoforms of phospholipase A2 and is differently regulated by cyclic AMP and Ca2+.

Authors:  Mikhail Strokin; Marina Sergeeva; Georg Reiser
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

Review 10.  The potential of p38 MAPK inhibitors to modulate periodontal infections.

Authors:  Keith L Kirkwood; Carlos Rossa
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.